These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 28043602)

  • 21. Comparative Study of GeneXpert with ZN Stain and Culture in Samples of Suspected Pulmonary Tuberculosis.
    Agrawal M; Bajaj A; Bhatia V; Dutt S
    J Clin Diagn Res; 2016 May; 10(5):DC09-12. PubMed ID: 27437212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India.
    Gaude GS; Hattiholli J; Kumar P
    Niger Med J; 2014 Jul; 55(4):327-32. PubMed ID: 25114369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
    Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Xpert(®) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Kim YW; Seong MW; Kim TS; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1216-21. PubMed ID: 26459536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda.
    Pho MT; Deo S; Palamountain KM; Joloba ML; Bajunirwe F; Katamba A
    PLoS One; 2015; 10(4):e0122574. PubMed ID: 25830297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
    Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light Emitting Diode Fluorescence Microscopy increased the detection of smear-positives during follow-up of Tuberculosis patients in India: program implications.
    Thapa B; Reza LW; Kumar AM; Pandey A; Satyanarayana S; Chadha S
    BMC Res Notes; 2015 Oct; 8():596. PubMed ID: 26499322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolongation of Acid-Fast Bacilli Sputum Smear Positivity in Patients with Multidrug-Resistant Pulmonary Tuberculosis.
    Mvo S; Bokop C; Longo-Mbenza B; Vasaikar SD; Apalata T
    Pathogens; 2023 Sep; 12(9):. PubMed ID: 37764941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of multi-drug resistant tuberculosis in Ekiti and Ondo states, Nigeria.
    Olabiyi OE; Okiki PA; Adarabioyo MI; Adebiyi OE; Adegoke OE; Esan OE; Idris OO; Agunbiade TB
    New Microbes New Infect; 2023 Oct; 55():101192. PubMed ID: 38046896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali.
    Baya B; Achenbach CJ; Kone B; Toloba Y; Dabitao DK; Diarra B; Goita D; Diabaté S; Maiga M; Soumare D; Ouattara K; Kanoute T; Berthe G; Kamia YM; Sarro YDS; Sanogo M; Togo ACG; Dembele BPP; Coulibaly N; Kone A; Akanbi M; Belson M; Dao S; Orsega S; Siddiqui S; Doumbia S; Murphy RL; Diallo S
    Int J Infect Dis; 2019 Apr; 81():149-155. PubMed ID: 30772470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar.
    Kyaw NTT; Sithu A; Satyanarayana S; Kumar AMV; Thein S; Thi AM; Wai PP; Lin YN; Kyaw KWY; Tun MMT; Oo MM; Aung ST; Harries AD
    Trop Med Infect Dis; 2019 Dec; 5(1):. PubMed ID: 31881646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D level and it is association with the severity of pulmonary tuberculosis in patients attended to Kosti Teaching Hospital, Sudan.
    Elsafi SSMS; Nour BM; Abakar AD; Omer IH; Almugadam BS
    AIMS Microbiol; 2020; 6(1):65-74. PubMed ID: 32226915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin.
    Ade S; Adjibodé O; Wachinou P; Toundoh N; Awanou B; Agodokpessi G; Affolabi D; Adè G; Harries AD; Anagonou S
    Tuberc Res Treat; 2016; 2016():1468631. PubMed ID: 27110400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-Resistant Moderate Tubercular Pleural Effusion: A Rare Case Presentation.
    Tiwari A; Wagh P
    Cureus; 2024 Mar; 16(3):e56239. PubMed ID: 38618456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nationwide HIV-, MDR-TB survey in Japan and collaborative study in the Philippines.
    Hattori T; Kobayashi N; Nagai H; Chagan-Yasutan H; Telan E; Solante MB
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S18-S19. PubMed ID: 28043540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi.
    Zhang A; Jumbe E; Krysiak R; Sidiki S; Kelley HV; Chemey EK; Kamba C; Mwapasa V; García JI; Norris A; Pan XJ; Evans C; Wang SH; Kwiek JJ; Torrelles JB
    Afr J Lab Med; 2018; 7(1):690. PubMed ID: 29977794
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.